Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: In vitro/in vivo evaluation

International Journal of Pharmaceutics

Volumn 453, Issue 2, 2013, Pages 569-578

  Fouad, Shahinaze A ^a   Basalious, Emad B ^b   El Nabarawi, Mohamed A ^b   Tayel, Saadia A ^b  

^a 4th Industrial Zone   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

D optimal design; Diclofenac epolamine; In skin depot; Microemulsion; Sustained transdermal delivery

Indexed keywords

DICLOFENAC EPOLAMINE; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; EXPERIMENTAL DESIGN; IN VITRO STUDY; IN VIVO STUDY; MICROEMULSION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 84884138493     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.009     Document Type: Article

References (30)

1. Azeem, A., Ahmad, F.J., Khar, R.K., Talegaonkar, S., 2009. Nanocarrier for the transdermal delivery of an antiparkinsonian drug. AAPS PharmSciTech 10, 1093-1103.
2. Barot, B.S., Parejiya, P.B., Patel, H.K., Gohel, M.C., Shelat, P.K., 2012. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS PharmSciTech 13, 184-192.
3. Basalious, E., Shawky, N., Badr-Eldin, S.M., 2010. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine I: development and optimization. Int. J. Pharm. 391, 203-211.
4. Binks, B.P., Meunier, J., Langevin, D., 1989. Characteristic sizes film rigidity and interfacial tension in microemulsion systems. Prog. Colloid Polym. Sci. 79, 208-213.
5. Chang, J.Y., Oh, Y.K., Choi, H.G., Kim, Y.B., Kim, C.K., 2002. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int. J. Pharm. 241, 155-163. (Pubitemid 34667075)
6. Chen, H., Chang, X., Du, D., Li, J., Xu, H., Yang, X., 2006. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm. 315, 52-58. (Pubitemid 43674110)
7. Conte, A., Ronca, G., Petrini, M., Mautone, G., 2002. Effect of lecithin on epicutaneous absorption of diclofenac epolamine. Drugs Exp. Clin. Res. 28, 249-255. (Pubitemid 36596890)
8. Gao, P., Witt, M.J., Haskell, R.J., Zamora, K.M., Shifflett, J.R., 2004. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm. Dev. Technol. 9, 301-309. (Pubitemid 39166282)
9. Holm, R., Jensen, I.H., Sonnergaard, J., 2006. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev. Ind. Pharm. 32, 1025-1032. (Pubitemid 44521820)
10. Huang, Y.B., Tsai, Y.H., Lee, S.H., Chang, J.S., Wu, P.C., 2005. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int. J. Pharm. 289, 87-95.
11. Huang, Y.B., Tsai, Y.H., Yang, W.C., Chang, J.S., Wu, P.C., Takayama, K., 2004. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 58, 607-614. (Pubitemid 39297107)
12. Kreilgaard, M., 2002. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 54 (Suppl. 1), S77-S98. (Pubitemid 35379956)
13. Kreilgaard, M., Pedersen, E.J., Jaroszewski, J.W., 2000. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J. Control. Release 69, 421-433.
14. Kweon, J.H., Chi, S.C., Park, E.S., 2004. Transdermal delivery of diclofenac using microemulsions. Arch. Pharm. Res. 27, 351-356.
15. Lawrence, M.J., Rees, G.D., 2000. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45, 89-121.
16. Malcolmson, C., Lawrence, M.J., 1993. A comparison of the incorporation of model steroids into non-ionic micellar and microemulsion systems. J. Pharm. Pharmacol. 45, 141-143. (Pubitemid 23081894)
17. Malcolmson, C., Satra, C., Kantaria, S., Sidhu, A., Lawrence, M.J., 1998. Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions. J. Pharm. Sci. 87, 109-116. (Pubitemid 28079271)
18. McCarberg, B.H., Argoff, C.E., 2010. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int. J. Clin. Pract. 64, 1546-1553.
19. O'Connor, K.M., Corrigan, O.I., 2001. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. Int. J. Pharm. 222, 281-293. (Pubitemid 32568371)
20. Petersen, B., Rovati, S., 2009. Diclofenac epolamine (Flector) patch: evidence for topical activity. Clin. Drug Investig. 29, 1-9.
21. Rhee, Y.S., Choi, J.G., Park, E.S., Chi, S.C., 2001. Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 228, 161-170.
22. Sarigullu Ozguney, I., Yesim Karasulu, H., Kantarci, G., Sozer, S., Guneri, T., Ertan, G., 2006. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech 7, 88.
23. Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, R.K., Ali, M., 2007. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 8 (Article 28).
24. Shah, R., Magdum, M., Patil, S., Niakwade, S., 2010. Preparation and evaluation of aceclofenac topical microemulsion. Iran. J. Pharm. Res. 9 (1), 5-11.
25. Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M., Shafiq, S., 2007. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8, E104.
26. Shin, S.C., Cho, C.W., Choi, H.K., 1999. Permeation of piroxicam from the poloxamer gels. Drug Dev. Ind. Pharm. 25, 273-278.
27. Trotta, M., Morel, S., Gasco, M.R., 1997. Effect of oil phase composition on the skin permeation of felodipine from o/w microemulsions. Pharmazie 52, 50-53. (Pubitemid 127491519)
28. Winter, C.A., Risley, E.A., Nuss, G.W., 1963. Anti-inflammatory and antipyretic activities of indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2- methylindole-3-acetic acid. J. Pharmacol. Exp. Ther. 141, 369-376.
29. Xuan, X.Y., 2011. Lecithin-linker microemulsion-based gels for drug delivery. Department of Chemical Engineering and Applied Chemistry, University of Toronto (Master Thesis) https://tspace.library.utoronto.ca/bitstream/1807/ 32214/1/Xuan-Xiao-Y-201111-MASc-thesis.pdf
30. Yuan, J.S., Acosta, E.J., 2009. Extended release of lidocaine from linker-based lecithin microemulsions. Int. J. Pharm. 368, 63-71.